Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.910
-0.020 (-0.68%)
At close: Mar 27, 2026
Zhaoke Ophthalmology Revenue
In the year 2025, Zhaoke Ophthalmology had annual revenue of 31.97M CNY, down -53.88%. Zhaoke Ophthalmology had revenue of 16.17M in the half year ending December 31, 2025, with 117.18% growth.
Revenue
31.97M CNY
Revenue Growth
-53.88%
P/S Ratio
44.88
Revenue / Employee
118.42K CNY
Employees
270
Market Cap
1.60B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.97M | -37.35M | -53.88% |
| Dec 31, 2024 | 69.32M | 50.57M | 269.73% |
| Dec 31, 2023 | 18.75M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Frontage Holdings | 1.99B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.43B |
| Mabpharm | 464.53M |
| Cutia Therapeutics | 374.07M |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 134.60M |
| CANbridge Pharmaceuticals | 68.55M |
| Beijing Biostar Pharmaceuticals | 58.66M |
| Kintor Pharmaceutical | 12.04M |